223 related articles for article (PubMed ID: 25496771)
1. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
Crow AR; Amash A; Lazarus AH
Transfusion; 2015 Jun; 55(6 Pt 2):1492-500. PubMed ID: 25496771
[TBL] [Abstract][Full Text] [Related]
2. Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP.
Leontyev D; Katsman Y; Branch DR
Blood; 2012 May; 119(22):5261-4. PubMed ID: 22508937
[TBL] [Abstract][Full Text] [Related]
3. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?
Crow AR; Song S; Suppa SJ; Ma S; Reilly MP; Andre P; McKenzie SE; Lazarus AH
Blood; 2011 Jan; 117(3):971-4. PubMed ID: 21045192
[TBL] [Abstract][Full Text] [Related]
5. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
Leontyev D; Katsman Y; Ma XZ; Miescher S; Käsermann F; Branch DR
Transfusion; 2012 Aug; 52(8):1799-805. PubMed ID: 22257295
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects.
Yu X; Menard M; Seabright G; Crispin M; Lazarus AH
Transfusion; 2015 Jun; 55(6 Pt 2):1501-11. PubMed ID: 25752470
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.
Crow AR; Yu H; Han D; Lazarus AH
PLoS One; 2013; 8(8):e71882. PubMed ID: 23940791
[TBL] [Abstract][Full Text] [Related]
8. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.
Crow AR; Song S; Freedman J; Helgason CD; Humphries RK; Siminovitch KA; Lazarus AH
Blood; 2003 Jul; 102(2):558-60. PubMed ID: 12649142
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.
Song S; Crow AR; Siragam V; Freedman J; Lazarus AH
Blood; 2005 Feb; 105(4):1546-8. PubMed ID: 15479722
[TBL] [Abstract][Full Text] [Related]
10. The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.
Crow AR; Suppa SJ; Chen X; Mott PJ; Lazarus AH
Blood; 2011 Dec; 118(24):6403-6. PubMed ID: 22001393
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
Tremblay T; Paré I; Bazin R
Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
Song S; Crow AR; Freedman J; Lazarus AH
Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
Crow AR; Song S; Siragam V; Lazarus AH
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.
Siragam V; Crow AR; Brinc D; Song S; Freedman J; Lazarus AH
Nat Med; 2006 Jun; 12(6):688-92. PubMed ID: 16715090
[TBL] [Abstract][Full Text] [Related]
15. GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.
Lewis BJB; Leontyev D; Neschadim A; Blacquiere M; Branch DR
Clin Exp Immunol; 2018 Sep; 193(3):293-301. PubMed ID: 29704458
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain.
Leontyev D; Neschadim A; Branch DR
Transfusion; 2014 Nov; 54(11):2871-9. PubMed ID: 24826802
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.
Samuelsson A; Towers TL; Ravetch JV
Science; 2001 Jan; 291(5503):484-6. PubMed ID: 11161202
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition.
Norris PAA; Kaur G; Khan R; Zhu G; Ni H; Lazarus AH
Blood; 2021 Apr; 137(15):2114-2124. PubMed ID: 33662988
[TBL] [Abstract][Full Text] [Related]
19. Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors.
Nishimoto T; Okazaki Y; Numajiri M; Kuwana M
Int J Hematol; 2017 May; 105(5):598-605. PubMed ID: 28028748
[TBL] [Abstract][Full Text] [Related]
20. Improved mouse models for the study of treatment modalities for immune-mediated platelet destruction.
Katsman Y; Foo AH; Leontyev D; Branch DR
Transfusion; 2010 Jun; 50(6):1285-94. PubMed ID: 20088841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
